Fundamentals of Decentralized Clinical Trials: Strategy and Execution
Sold by Open Books, Chicago, IL, U.S.A.
AbeBooks Seller since 14 October 2016
Used - Soft cover
Condition: Used - Fine
Ships within U.S.A.
Quantity: 2 available
Add to basketSold by Open Books, Chicago, IL, U.S.A.
AbeBooks Seller since 14 October 2016
Condition: Used - Fine
Quantity: 2 available
Add to basketOpen Books is a nonprofit social venture that provides literacy experiences for thousands of readers each year through inspiring programs and creative capitalization of books.
Seller Inventory # mon0000835628
A timely and first-of-its-kind publication in the field, this short handbook on decentralized clinical trials (DCTs) offers a thorough exploration of the potential of DCTs to revolutionize clinical research through innovative approaches, including technology. This concise and easy-to-read publication is especially designed for those who seek to understand and get up-to-speed on what DCTs mean and how to work in this rapidly evolving field. As discussed in Chapter 1, DCTs address barriers to traditional trial participation, promoting accessibility, diversity, equity, and participant engagement. Chapter 2 examines how the COVID-19 pandemic and evolving regulations accelerated the adoption of DCTs, building on their application since the early 2000s. Chapters 3 and 4 highlight remaining operational complexities and the importance of careful trial design to ensure scientific rigor, operational feasibility, and compliance with regulations, ethics, data privacy, and participant safety. The book emphasizes the significance of the FDA's draft guidance on DCTs, detailing investigator responsibilities, local health care providers' use, and essential sponsor considerations. Chapter 5 stresses the need for clear metrics to evaluate DCT adoption's impact on recruitment, retention, diversity, safety, and cost efficiencies. Overall, this guide tracks DCT advancements and encourages readers to contribute to evidence-based integration, meeting participant expectations for convenience and fostering faster, more inclusive clinical studies. Ultimately, this book aims to support the transformation of modern clinical research, developing medical products more efficiently for those in need. A major contribution to the literature on clinical research, this work will be a resourceful tool to anyone interested in embracing decentralized clinical research and improving access and participation for all.
Dr. Yang is a Principal Clinical Innovation and Technology Leader in the US Medical Affairs Evidence Generation Team at Genentech. Anna leads discussions related to DCT strategy and implementation with study teams across the portfolio, infusing insights and best practices from industry partners. Anna cares deeply about inspiring change in the lagging adopters by sharing important lessons learned and reshaping assumptions. Anna is also curious about quantifying the value of DCT approaches and is actively involved with DTRA and the Tufts PACT cross-industry collaborations. Anna received her PharmD at the Rutgers Ernest Mario School of Pharmacy and completed a postdoctoral fellowship in the Genentech BioOncology Medical Science Liaisons team.
Dr. Rodriguez-Chavez is a preeminent clinical research and regulatory affairs leader who has forged a distinguished 30-year career in infectious diseases, immunology, oncology, vaccines and rare diseases. His expertise spans the entire medical product lifecycle. Previously Senior Vice President at ICON plc, spearheading DCTs and digital medicine strategies. He is also a former U.S. FDA Senior Official who developed the draft guidance on DCTs with FDA colleagues and made pivotal contributions to modernize clinical research by using digital health technologies (DHTs). He has authored 60+ publications, delivered 151+ global presentations, and his contributions on DCTs and DHTs resonate through industry, academia and non-for-profit enterprises.
"About this title" may belong to another edition of this title.
All items subject to prior sale. Refunds and returns within 30 days of shipment with authorization.
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Open Books, Chicago, Illinois, U.S.A., +1 312-243-9776, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
All orders ship within 2 business days. Most domestic orders shipped with USPS Bound Printed Matter with delivery confirmation, delivery within 2 weeks. Expedited orders ship via USPS Priority Mail. International Orders ship via USPS International Prioriry, delivery between 7-21 business days. Standard intenrational shipping is expedited service.
| Order quantity | 5 to 14 business days | 3 to 6 business days |
|---|---|---|
| First item | £ 3.02 | £ 6.04 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.